SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-15-002518
Filing Date
2015-10-08
Accepted
2015-10-08 17:25:21
Documents
3
Period of Report
2015-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K entiabiosciences8k100815.htm 8-K 28878
2 EX-10.1 ex10-1.htm EX-10.1 139906
3 EX-10.2 ex10-2.htm EX-10.2 129310
  Complete submission text file 0001185185-15-002518.txt   299753
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 844-559-9910
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52864 | Film No.: 151151509
SIC: 2833 Medicinal Chemicals & Botanical Products